Back
Nuvalent Vs. Pfizer Industry Stock Comparison
Sell
44
NUVL
Nuvalent
Last Price:
$71.60
Seasonality Move:
36.77%
Sell
48
PFE
Pfizer
Last Price:
$23.14
Seasonality Move:
1.95%
Sell
44
Nuvalent (NUVL)
is a Sell
Is Nuvalent a Buy, Sell or Hold?
-
NUVL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Pfizer (PFE)
is a Sell
Is Pfizer a Buy, Sell or Hold?
-
PFE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PFE Stock Price Chart
NUVL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 49.34 | Sell |
Chaikin Money Flow: | -345183 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (70.53 - 75.63) | Sell |
Bollinger Bands (100): | (69.61 - 81.17) | Sell |
PFE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 54.14 | Buy |
Chaikin Money Flow: | 23553376 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.53 - 23.69) | Buy |
Bollinger Bands (100): | (23.24 - 26.6) | Sell |
NUVL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 73.27 | Sell |
20-day SMA: | 73.02 | Sell |
50-day SMA: | 71.99 | Buy |
200-day SMA: | 83.34 | Sell |
8-day EMA: | 73.04 | Sell |
20-day EMA: | 72.67 | Sell |
50-day EMA: | 73.1 | Sell |
200-day EMA: | 77.77 | Sell |
PFE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.12 | Buy |
20-day SMA: | 23.2 | Buy |
50-day SMA: | 23.58 | Buy |
200-day SMA: | 26.4 | Sell |
8-day EMA: | 23.19 | Buy |
20-day EMA: | 23.12 | Buy |
50-day EMA: | 23.64 | Sell |
200-day EMA: | 25.91 | Sell |
Nuvalent Earnings Growth & NUVL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.90 per share, and a decrease next year of $0.06 per share.
Pfizer Earnings Growth & PFE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.27 per share, an increase this year of $0.07 per share, and an increase next year of $0.09 per share.
Nuvalent Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pfizer Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |